undamentalytics Newsletter
Sign in

Vericel Corp balance sheet

At the end of fiscal 2025, Vericel Corp had total assets of $488m, total liabilities of $133m and shareholders' equity of $355m. It held $100m in cash against $0 of debt: net cash of $100m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jun 20092010Jun 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents——6148——232718273468516975100125
Receivables——0008111718233235374758618576
Inventory—————2134479131613171818
Total current assets——614841274551113112124158187206213247265
Total assets——815948344955119153206244273354433488503
Accounts payable——233687676791722241621
Deferred revenue (current)———————00—————————
Total current liabilities——216512121313152022263746504953
Short-term debt——000—————————————
Long-term debt——00—00917—————————
Total debt00000009171300000000
Total liabilities——2165121224321642717381128141133133
Shareholders' equity1715−13−32436222523102111134170192226292355370
Non-controlling interests and other (assets − liabilities − equity)———42——————————————
Net debt (negative = net cash)——−5−14−8——−14−10−5−27−34−68−51−69−75−100−125
Shares outstanding———18m24m24m24m—36m44m45m46m47m47m48m50m51m51m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ADPT vs VCELVCEL vs VIRARVN vs VCELIOVA vs VCEL

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Vericel Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Vericel Corp.